Comprehensive revelation! The trading tactics behind SOL exposed, how can retail investors profit?
A fierce operation like a tiger, the rise and fall all depend on 205. When the non-farm payrolls shock, global assets tremble, and SOL is also testing its direction in the tug-of-war of long and short positions!
This week, the market was dominated by the US non-farm payroll data: in August, non-farm employment increased by only 22,000, far below expectations, and the unemployment rate rose to 4.3%. Once this data was released, the market immediately bet that the Federal Reserve would accelerate interest rate cuts, gold surged to a new high of 3600 USD, and the dollar plummeted in the short term. In this macro environment, risk assets like SOL are naturally swept along by the flow of funds.
Technical analysis: SOL's movement today can be summed up as 'seeking breakthroughs amidst fluctuations'
From a technical perspective, SOL is currently stuck at a key position: resistance above at 205-209 USD,
support below in the 195-200 USD range. The 1-hour candlestick chart shows that the price is repeatedly testing around 201 USD, with both long and short positions consuming energy here—breaking below 195 may trigger a deeper correction to 188, while breaking above 205 could open a new round of increases. Recently, trading volume has shrunk, and the market feels a bit 'quiet', indicating that everyone is waiting to see the direction.
My view is: SOL looks volatile in the short term, but is bullish in the medium term.
Why? Two points:
1. Macroeconomic benefits are still present: Poor non-farm data has heated expectations for interest rate cuts. The expectation of liquidity easing is good for cryptocurrencies, and funds may flow back into risk assets.
2. Institutions are still bottom-fishing: Although retail investors are hesitant, institutional actions have not stopped.
For example, the US-listed company DeFi Development Corporation just increased its holdings of 196,000 SOL at an average price of 202.76 USD, and the biological sample company iSpecimen also plans to build a 200 million USD asset pool by purchasing SOL through OTC.
These 'big funds' are buying in at low levels, indicating their recognition of SOL's long-term value.
If you are unclear about the specific points, you can pay attention to @船长趋势 , 24-hour real-time reminders for friends who have followed me, and keep an eye on my homepage
